GLP-1 use rising rapidly among US adolescents and young adults, study finds
GLP-1 weight-loss medications are seeing a rapid increase in use among adolescents and young adults globally.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Usage of GLP-1 medications is rising rapidly among adolescents and young adults in the US. This shift coincides with a decline in bariatric surgery rates for youth.
Coverage indicates that Ozempic is becoming a primary weight-loss treatment for teenagers. Reports from Medical Xpress, AJMC, and Gizmodo highlight the trend in the US.
Internationally, The Times reports that state-funded weight-loss jabs will be available to children as young as 12, while Khaleej Times notes that parents in the UAE are increasingly seeking these injections for their children. Future developments center on the expanded availability of state-funded treatments for children and the continued adoption of GLP-1s as an alternative to surgical interventions.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
How is GLP-1 use affecting other weight-loss methods?
According to the American Journal of Managed Care, GLP-1 use in youth is climbing as rates of bariatric surgery fall.
Which countries are reporting an increase in youth GLP-1 requests?
Coverage identifies rising use and demand among youth in the US and the UAE.
What is the minimum age for state-funded jabs in some regions?
The Times reports that children as young as 12 may receive state-funded weight-loss injections.
Coverage (5)
- UAE parents increasingly seek weight-loss injections for children amid GLP-1 buzz Khaleej Times · 1d ago
- GLP-1 Use in Youth Climbs as Bariatric Surgery Rates Fall The American Journal of Managed Care® (AJMC®) · 1d ago
- Children as young as 12 to get state-funded weight-loss jabs The Times · 1d ago
- Ozempic Is Quietly Becoming the Go-to Weight Loss Treatment for Teens Gizmodo · 1d ago
- GLP-1 use rising rapidly among US adolescents and young adults, study finds Medical Xpress · 1d ago
Topics
Related trends
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging the rival company used false and misleading advertising regarding weight-loss drug efficacy.
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging the use of misleading and deceptive advertising for GLP-1 weight-loss drugs.
Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness - WSB-TV
Legal action and medical analyses are emerging over a potential link between GLP-1 weight loss drugs and permanent vision loss.
This GLP-1 retreat changed how I think about weight loss
Discussions around GLP-1 medications are expanding from weight loss to include holistic retreats, psychological impacts, and broader health benefits.
24 GLP-1 Users Reveal The Good, The Bad, And The Shocking Side Effects
Rapid growth in GLP-1 drug adoption is sparking new discussions on side effects, lifestyle requirements, and the social dilemmas of disclosure.
Your Smartphone Is Changing Your Body. Doctors Say Most People Don't Know It's Happening
Medical reports highlight physical health concerns linked to prolonged smartphone use and postural habits.